Skip to main content
Equibles
TTRX logo

TTRX · Turn Therapeutics Inc. · Exempt Offerings

Track TTRX — free

Use TTRX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TTRX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.48 +0.54 (+6.04%) At close · Nov 6
Rebalance outlook locked
Going-concern doubt — flagged Aug 12, 2026

Substantial doubt about the company's ability to continue as a going concern.

“Our capital resources may not be sufficient to fund operations through at least the next 12 months from the date that the accompanying unaudited condensed consolidated interim financial statements as of June 30, 2026 are issued based on our expected cash needs, which raises substantial doubt about our ability to continue as a going concern.”
View the 10-Q filed Aug 12, 2026
Market Cap
$282.39M
Shares
29.79M
Volume · Nov 6 98.14K Avg daily vol (3M) 110.55K

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2026-08-26 New Indefinite $1,650,000
Showing 1–1 of 1 filings
Key facts CIK 2023016 CUSIP 90021W105 13F (30d) 16 filings 16 filers Visit website Investor relations